Amsterdam, Netherlands

Gloria Ten Figas


 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Inventor Spotlight: Gloria Ten Figas

Introduction

Gloria Ten Figas is an innovative inventor based in Amsterdam, Netherlands, known for her contributions in the pharmaceutical field. With a total of four patents to her name, she has made significant strides in the formulation of new crystalline forms of established compounds.

Latest Patents

Her latest inventions focus on polymorphic forms of minocycline base and the processes for their preparation. The present inventions include two new crystalline polymorphic forms designated as Form IV and Form V. These forms are characterized by advanced analytical methods such as X-Ray Diffraction (XRD), Fourier-Transform Infrared Spectroscopy (FTIR), and Thermogravimetric Analysis (TGA). The processes for preparing these new polymorphic forms involve the dissolution and/or suspension of minocycline base in an organic solvent, followed by crystallization. These novel formulations have the potential for use in various pharmaceutical compositions.

Career Highlights

Throughout her career, Gloria has been affiliated with notable companies such as Hovione Scientia Limited and Wavelength Enterprises Ltd. Her work in these organizations has greatly influenced her research and development in the pharmaceutical sector. Gloria's meticulous approach to innovation has allowed her to create significant advancements in drug formulation.

Collaborations

In her professional journey, Gloria has collaborated with esteemed coworkers, including Ana Fernandez Casares and Itai Adin. These partnerships have fostered an environment of creativity and innovation, further propelling her research and contributions to the field.

Conclusion

Gloria Ten Figas is an exemplary inventor whose work in developing new polymorphic forms of minocycline exemplifies the importance of innovation in pharmaceuticals. With her ongoing contributions and collaborative efforts, she continues to make a notable impact in the realm of medical science and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…